tag :: b, Infections,

bookmarks (hide)
display
all
bookmarks only
bookmarks per page
5
10
20
50
100
sort by
added at
title
RSS
BibTeX
XML

No matching posts.

⟨⟨
⟨
⟩
⟩⟩

publications (hide)25
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...

1Biochemical characterization of a Neisseria meningitidis polysialyltransferase reveals novel functional motifs in bacterial sialyltransferases
F. Freiberger, H. Claus, A. GĂźnzel, I. Oltmann-Norden, J. Vionnet, M. MĂźhlenhoff, U. Vogel, W. Vann, R. Gerardy-Schahn, and K. Stummeyer. Molecular Microbiology, 65 (5): 1258--1275 (September 2007)PMID: 17662040.
14 years ago by @ag_vogel
show all tags
,
Acid
Acids,
Adolescent,
Alignment,
Amino
B,
Bacterial
Binding
Child,
Conformation,
Data,
Fusion
Humans,
Infections,
Meningococcal
Models,
Molecular
Molecular,
Mutagenesis,
Neisseria
Protein
Proteins,
Recombinant
Sequence
Sequence,
Serogroup
Sialic
Sialyltransferases
Sites,
bacterial_capsules
meningitidis,
{Site-Directed},
,AcidAcids,Adolescent,Alignment,AminoB,BacterialBindingChild,Conformation,Data,FusionHumans,Infections,MeningococcalModels,MolecularMolecular,Mutagenesis,NeisseriaProteinProteins,RecombinantSequenceSequence,SerogroupSialicSialyltransferasesSites,bacterial_capsulesmeningitidis,{Site-Directed},
(0)
copydeleteadd this publication to your clipboard
1Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence
B. Joseph, S. Schneiker-Bekel, A. Schramm-GlĂźck, J. Blom, H. Claus, B. Linke, R. Schwarz, A. Becker, A. Goesmann, M. Frosch and 1 other author(s). Journal of Bacteriology, 192 (20): 5363--5377 (October 2010)PMID: 20709895.
14 years ago by @ag_vogel
show all tags
Adhesion,
B,
Bacterial
Bacterial,
Cell
Expression
Gene
Genome,
Genotype,
Humans,
Infections,
Interspersed
Line,
Membrane
Meningococcal
Neisseria
Outer
Phylogeny,
Profiling,
Proteins,
Regulation,
Repetitive
Sequences,
Serogroup
Virulence
meningitidis,
Adhesion,B,BacterialBacterial,CellExpressionGeneGenome,Genotype,Humans,Infections,InterspersedLine,MembraneMeningococcalNeisseriaOuterPhylogeny,Profiling,Proteins,Regulation,RepetitiveSequences,SerogroupVirulencemeningitidis,
(0)
copydeleteadd this publication to your clipboard
2Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence
B. Joseph, S. Schneiker-Bekel, A. Schramm-Glück, J. Blom, H. Claus, B. Linke, R. Schwarz, A. Becker, A. Goesmann, M. Frosch and 1 other author(s). Journal of Bacteriology, 192 (20): 5363--5377 (October 2010)PMID: 20709895.
14 years ago by @hymi
show all tags
Adhesion,
B,
Bacterial
Bacterial,
Cell
Expression
Gene
Genome,
Genotype,
Humans,
Infections,
Interspersed
Line,
Membrane
Meningococcal
Neisseria
Outer
Phylogeny,
Profiling,
Proteins,
Regulation,
Repetitive
Sequences,
Serogroup
Virulence
ag_schoen
meningitidis,
Adhesion,B,BacterialBacterial,CellExpressionGeneGenome,Genotype,Humans,Infections,InterspersedLine,MembraneMeningococcalNeisseriaOuterPhylogeny,Profiling,Proteins,Regulation,RepetitiveSequences,SerogroupVirulenceag_schoenmeningitidis,
(0)
copydeleteadd this publication to your clipboard
4Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany
J. Elias, L. Schouls, I. van de Pol, W. Keijzers, D. Martin, A. Glennie, P. Oster, M. Frosch, U. Vogel, and A. van der Ende. Emerging Infectious Diseases, 16 (3): 465--472 (March 2010)PMID: 20202422.
14 years ago by @hymi
show all tags
B,
Bactericidal
Child,
Disease
Germany,
Humans,
Incidence,
Infant,
Infections,
Meningococcal
Neisseria
Netherlands,
Outbreaks,
Preschool,
Serogroup
Serum
Test
Vaccines,
ag_vogel
meningitidis,
B,BactericidalChild,DiseaseGermany,Humans,Incidence,Infant,Infections,MeningococcalNeisseriaNetherlands,Outbreaks,Preschool,SerogroupSerumTestVaccines,ag_vogelmeningitidis,
(0)
copydeleteadd this publication to your clipboard
1New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery
K. Dyet, A. Devoy, R. McDowell, and D. Martin. Vaccine, 23 (17-18): 2228--30 (March 2005)PMID: 15755601.
14 years ago by @jelias
show all tags
Adolescent,
Adult,
B,
Bacterial
Bacterial,
Chain
Child,
Disease
Epidemiology,
Ethnic
Groups,
Humans,
Infant,
Infections,
Meningococcal
Molecular,
Neisseria
New
Outbreaks,
Polymerase
Preschool,
Reaction
Serogroup
Vaccines,
Zealand,
meningitidis,
{DNA,}
Adolescent,Adult,B,BacterialBacterial,ChainChild,DiseaseEpidemiology,EthnicGroups,Humans,Infant,Infections,MeningococcalMolecular,NeisseriaNewOutbreaks,PolymerasePreschool,ReactionSerogroupVaccines,Zealand,meningitidis,{DNA,}
(0)
copydeleteadd this publication to your clipboard
1The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB
D. Martin, N. Ruijne, L. McCallum, J. O'Hallahan, and P. Oster. Clinical and Vaccine Immunology: CVI, 13 (4): 486--91 (April 2006)PMID: 16603616.
14 years ago by @jelias
show all tags
Acid
Amino
Antibodies,
B,
Bacterial,
Child,
Controlled
Data,
Deletion
Epitopes,
Humans,
Infant,
Infections,
Meningococcal
Molecular
Neisseria
Porins,
Preschool,
Randomized
Sequence
Sequence,
Serogroup
Topic,
Trials
Vaccines,
as
meningitidis,
AcidAminoAntibodies,B,Bacterial,Child,ControlledData,DeletionEpitopes,Humans,Infant,Infections,MeningococcalMolecularNeisseriaPorins,Preschool,RandomizedSequenceSequence,SerogroupTopic,TrialsVaccines,asmeningitidis,
(0)
copydeleteadd this publication to your clipboard
1Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease
D. Bennett, and M. Cafferkey. Journal of Clinical Microbiology, 44 (3): 1127--1131 (March 2006)PMID: 16517911.
14 years ago by @jelias
show all tags
A,
B,
Bacterial,
Base
C,
Carrier
Chain
Humans,
Infections,
Meningococcal
Neisseria
Polymerase
Primers,
Reaction,
Sensitivity
Sequence,
Serogroup
Serotyping,
Specificity,
State,
Virulence
W-135,
Y,
and
meningitidis,
{DNA,}
{DNA}
A,B,Bacterial,BaseC,CarrierChainHumans,Infections,MeningococcalNeisseriaPolymerasePrimers,Reaction,SensitivitySequence,SerogroupSerotyping,Specificity,State,VirulenceW-135,Y,andmeningitidis,{DNA,}{DNA}
(0)
copydeleteadd this publication to your clipboard
1The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic
K. Sexton, D. Lennon, P. Oster, S. Crengle, D. Martin, K. Mulholland, T. Percival, S. Reid, J. Stewart, and J. O'Hallahan. The New Zealand Medical Journal, 117 (1200): U1015 (August 2004)PMID: 15475985.
14 years ago by @jelias
show all tags
B,
Disease
Factors
Humans,
Immunization
Infections,
Meningococcal
Neisseria
New
Outbreaks,
Population
Postmarketing,
Product
Programs,
Risk
Serogroup
Surveillance,
Vaccines,
Zealand,
meningitidis,
B,DiseaseFactorsHumans,ImmunizationInfections,MeningococcalNeisseriaNewOutbreaks,PopulationPostmarketing,ProductPrograms,RiskSerogroupSurveillance,Vaccines,Zealand,meningitidis,
(0)
copydeleteadd this publication to your clipboard
1Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005
CCDR. Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada, 33 (10): 1--15 (June 2007)PMID: 17691125.
14 years ago by @jelias
show all tags
80
Adolescent,
Adult,
Aged,
B,
C,
Canada,
Child,
Disease
Female,
Humans,
Incidence,
Infant,
Infections,
Male,
Meningococcal
Middle
Neisseria
Outbreaks,
Population
Preschool,
Seasons
Serogroup
Surveillance,
Vaccines,
W-135,
Y,
and
meningitidis,
over,
80Adolescent,Adult,Aged,B,C,Canada,Child,DiseaseFemale,Humans,Incidence,Infant,Infections,Male,MeningococcalMiddleNeisseriaOutbreaks,PopulationPreschool,SeasonsSerogroupSurveillance,Vaccines,W-135,Y,andmeningitidis,over,
(0)
copydeleteadd this publication to your clipboard
1Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B
S. Pillai, A. Howell, K. Alexander, B. Bentley, {. Jiang, K. Ambrose, D. Zhu, and G. Zlotnick. Vaccine, 23 (17-18): 2206--9 (March 2005)PMID: 15755596.
14 years ago by @jelias
show all tags
Animals,
Antibodies,
B,
Bacterial
Bacterial,
Humans,
Infections,
Membrane
Meningococcal
Mice,
Neisseria
Outer
Proteins,
Rats,
Serogroup
Synthetic
Vaccines,
meningitidis,
{Sprague-Dawley,}
Animals,Antibodies,B,BacterialBacterial,Humans,Infections,MembraneMeningococcalMice,NeisseriaOuterProteins,Rats,SerogroupSyntheticVaccines,meningitidis,{Sprague-Dawley,}
(0)
copydeleteadd this publication to your clipboard
1Assessing the risk of laboratory-acquired meningococcal disease
J. Sejvar, D. Johnson, T. Popovic, J. Miller, F. Downes, P. Somsel, R. Weyant, D. Stephens, B. Perkins, and N. Rosenstein. Journal of Clinical Microbiology, 43 (9): 4811--4 (September 2005)PMID: 16145146.
14 years ago by @jelias
show all tags
Adult,
Aged,
B,
C,
Exposure,
Factors
Female,
Humans,
Infection,
Infections,
Laboratories,
Laboratory
Male,
Meningococcal
Microbiology,
Middle
Neisseria
Occupational
Personnel,
Risk
Serogroup
meningitidis,
Adult,Aged,B,C,Exposure,FactorsFemale,Humans,Infection,Infections,Laboratories,LaboratoryMale,MeningococcalMicrobiology,MiddleNeisseriaOccupationalPersonnel,RiskSerogroupmeningitidis,
(0)
copydeleteadd this publication to your clipboard
1Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients
E. Haralambous, S. Dolly, M. Hibberd, D. Litt, I. Udalova, C. O'dwyer, P. Langford, J. Kroll, and M. Levin. Scandinavian Journal of Infectious Diseases, 38 (9): 764--71 (2006)PMID: 16938729.
14 years ago by @jelias
show all tags
Activity,
Adolescent,
Adult,
Aged,
Alleles,
Ancestry
B,
Bactericidal
Binding,
Blood
Britain,
Child,
Cohort
Complement
Continental
Disease
Disease,
European
Factor
Family
Genetic
Great
Group,
H,
Health,
Homozygote,
Humans,
Infant,
Infections,
Meningococcal
Middle
Nucleotide,
Polymorphism,
Predisposition
Preschool,
Protein
Single
Statistics
Studies,
Susceptibility,
Topic
as
to
{Case-Control}
{NF-kappa}
Activity,Adolescent,Adult,Aged,Alleles,AncestryB,BactericidalBinding,BloodBritain,Child,CohortComplementContinentalDiseaseDisease,EuropeanFactorFamilyGeneticGreatGroup,H,Health,Homozygote,Humans,Infant,Infections,MeningococcalMiddleNucleotide,Polymorphism,PredispositionPreschool,ProteinSingleStatisticsStudies,Susceptibility,Topicasto{Case-Control}{NF-kappa}
(0)
copydeleteadd this publication to your clipboard
1Delivering a safe and effective strain-specific vaccine to control an epidemic of group B meningococcal disease
J. O'Hallahan, A. McNicholas, Y. Galloway, E. O'Leary, and C. Roseveare. The New Zealand Medical Journal, 122 (1291): 48--59 (2009)PMID: 19322255.
14 years ago by @jelias
show all tags
Adolescent,
Ancestry
B,
Child,
Disease
Group,
Humans,
Immunization
Infant,
Infections,
Management
Meningococcal
Neisseria
New
Oceanic
Outbreaks,
Preschool,
Programs,
Risk
Schedule,
Serogroup
Vaccines,
Zealand,
meningitidis,
Adolescent,AncestryB,Child,DiseaseGroup,Humans,ImmunizationInfant,Infections,ManagementMeningococcalNeisseriaNewOceanicOutbreaks,Preschool,Programs,RiskSchedule,SerogroupVaccines,Zealand,meningitidis,
(0)
copydeleteadd this publication to your clipboard
1A prospective study of the effectiveness of the New Zealand meningococcal B vaccine
C. Kelly, R. Arnold, Y. Galloway, and J. O'Hallahan. American Journal of Epidemiology, 166 (7): 817--23 (October 2007)PMID: 17615088.
14 years ago by @jelias
show all tags
80
Adolescent,
Adult,
Aged,
Assessment,
B,
Child,
Confidence
Disease
Distribution,
Factors,
Female,
Humans,
Immunization
Infant,
Infections,
Intervals,
Male,
Meningococcal
Middle
Neisseria
New
Outcome
Poisson
Postmarketing,
Preschool,
Product
Programs,
Progression,
Prospective
Risk
Safety,
Serogroup
Studies,
Surveillance,
Treatment
Vaccines,
Zealand,
and
meningitidis,
over,
80Adolescent,Adult,Aged,Assessment,B,Child,ConfidenceDiseaseDistribution,Factors,Female,Humans,ImmunizationInfant,Infections,Intervals,Male,MeningococcalMiddleNeisseriaNewOutcomePoissonPostmarketing,Preschool,ProductPrograms,Progression,ProspectiveRiskSafety,SerogroupStudies,Surveillance,TreatmentVaccines,Zealand,andmeningitidis,over,
(0)
copydeleteadd this publication to your clipboard
1Primary meningococcal conjunctivitis
B. Orden, R. Martínez, R. Millán, M. Belloso, and N. Pérez. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 9 (12): 1245--1247 (December 2003)PMID: 14686993.
14 years ago by @jelias
show all tags
Administration,
Agents,
B,
Bacterial,
Child,
Conjunctivitis,
Gramicidin,
Humans,
Infections,
Male,
Meningococcal
Neisseria
Neomycin,
Oral,
Polymyxin
Rifampin
Topical,
meningitidis,
{Anti-Bacterial}
Administration,Agents,B,Bacterial,Child,Conjunctivitis,Gramicidin,Humans,Infections,Male,MeningococcalNeisseriaNeomycin,Oral,PolymyxinRifampinTopical,meningitidis,{Anti-Bacterial}
(0)
copydeleteadd this publication to your clipboard
1Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines
M. Slack, D. Schapira, R. Thwaites, M. Burrage, J. Southern, N. Andrews, R. Borrow, D. Goldblatt, and E. Miller. The Journal of Infectious Diseases, 184 (12): 1617--1620 (December 2001)PMID: 11740740.
14 years ago by @jelias
show all tags
Antibodies,
Bacterial,
Combined,
Conjugate
Female,
Haemophilus
Humans,
Infant,
Infections,
Male,
Meningococcal
Neisseria
Newborn,
Polysaccharides,
Premature,
Vaccination,
Vaccine,
Vaccines,
Viral,
b,
influenzae
meningitidis,
type
{Diphtheria-Tetanus-Pertussis}
Antibodies,Bacterial,Combined,ConjugateFemale,HaemophilusHumans,Infant,Infections,Male,MeningococcalNeisseriaNewborn,Polysaccharides,Premature,Vaccination,Vaccine,Vaccines,Viral,b,influenzaemeningitidis,type{Diphtheria-Tetanus-Pertussis}
(0)
copydeleteadd this publication to your clipboard
1School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom
S. Oh, D. Griffiths, T. John, Y. Lee, L. Yu, N. McCarthy, P. Heath, D. Crook, M. Ramsay, E. Moxon and 1 other author(s). The Journal of Infectious Diseases, 197 (9): 1275--1281 (May 2008)PMID: 18422439.
14 years ago by @jelias
show all tags
Adult,
Antibodies,
Bacterial,
Britain,
Carrier
Child,
Disease
Great
Haemophilus
Humans,
Infections,
Pharynx,
Prevalence
Reservoirs,
State,
b,
influenzae
type
Adult,Antibodies,Bacterial,Britain,CarrierChild,DiseaseGreatHaemophilusHumans,Infections,Pharynx,PrevalenceReservoirs,State,b,influenzaetype
(0)
copydeleteadd this publication to your clipboard
1Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand
P. Oster, J. O'Hallahan, I. Aaberge, S. Tilman, E. Ypma, and D. Martin. Vaccine, 25 (16): 3075--9 (April 2007)PMID: 17289223.
14 years ago by @jelias
show all tags
Antibodies,
B,
Bacterial,
Child,
Humans,
Infant,
Infections,
Meningococcal
Neisseria
New
Pharmaceutical
Preparations,
Preschool,
Safety
Serogroup
Vaccines,
Zealand,
meningitidis,
Antibodies,B,Bacterial,Child,Humans,Infant,Infections,MeningococcalNeisseriaNewPharmaceuticalPreparations,Preschool,SafetySerogroupVaccines,Zealand,meningitidis,
(0)
copydeleteadd this publication to your clipboard
1Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed
M. Breukels, E. van der Zijde, M. van Tol, and G. Rijkers. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 34 (2): 191--7 (January 2002)PMID: 11740707.
14 years ago by @jelias
show all tags
A,
Affinity,
Antibodies,
Antibody
Bacterial,
Child,
Failure
G,
Haemophilus
Haemophilus,
Humans,
Immunization
Immunoglobulin
Infant,
Infections,
M,
Meningitis,
Preschool,
Schedule,
Treatment
Vaccines,
b,
influenzae
type
A,Affinity,Antibodies,AntibodyBacterial,Child,FailureG,HaemophilusHaemophilus,Humans,ImmunizationImmunoglobulinInfant,Infections,M,Meningitis,Preschool,Schedule,TreatmentVaccines,b,influenzaetype
(0)
copydeleteadd this publication to your clipboard
1Haemophilus influenzae type b conjugate vaccines
D. Kelly, E. Moxon, and A. Pollard. Immunology, 113 (2): 163--74 (October 2004)PMID: 15379976.
14 years ago by @jelias
show all tags
Bacterial,
Carrier
Child,
Conjugate
Failure,
Haemophilus
Humans,
Immunologic
Infant,
Infections,
Memory,
Polysaccharides,
Preschool,
Proteins,
Treatment
Vaccines,
b,
influenzae
type
Bacterial,CarrierChild,ConjugateFailure,HaemophilusHumans,ImmunologicInfant,Infections,Memory,Polysaccharides,Preschool,Proteins,TreatmentVaccines,b,influenzaetype
(0)
copydeleteadd this publication to your clipboard

⟨⟨
⟨
1
2
⟩
⟩⟩

BibSonomy

bookmarks (hide)
display
all
bookmarks only
bookmarks per page
5
10
20
50
100
sort by
added at
title
RSS
BibTeX
XML

publications (hide)25
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...

1Biochemical characterization of a Neisseria meningitidis polysialyltransferase reveals novel functional motifs in bacterial sialyltransferases

1Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence

2Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence

4Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany

1New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery

1The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB

1Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease

1The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic

1Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005

1Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B

1Assessing the risk of laboratory-acquired meningococcal disease

1Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients

1Delivering a safe and effective strain-specific vaccine to control an epidemic of group B meningococcal disease

1A prospective study of the effectiveness of the New Zealand meningococcal B vaccine

1Primary meningococcal conjunctivitis

1Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines

1School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom

1Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand

1Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed

1Haemophilus influenzae type b conjugate vaccines

browse

related tags

bookmarks (hide) displayallbookmarks onlybookmarks per page5102050100 sort byadded attitle RSSBibTeXXML

publications (hide)25 displayallpublications onlypublications per page5102050100 sort byadded attitleauthorpublication dateentry typehelp for advanced sorting... RSSBibTeXRDFmore...

browse

related tags

bookmarks (hide)
display
all
bookmarks only
bookmarks per page
5
10
20
50
100
sort by
added at
title
RSS
BibTeX
XML

publications (hide)25
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...